Viewing Study NCT07132333


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2025-12-31 @ 2:09 AM
Study NCT ID: NCT07132333
Status: RECRUITING
Last Update Posted: 2025-08-20
First Post: 2025-08-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Molecular Inflammation Board at the Center for Personalized Medicine
Sponsor: University Hospital Tuebingen
Organization:

Study Overview

Official Title: The Molecular Inflammation Board at the Centers for Personalized Medicine at the University Hospitals of Freiburg, Heidelberg, Tübingen and Ulm - A Multicenter Prospective Observational Study
Status: RECRUITING
Status Verified Date: 2025-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MEB@ZPM
Brief Summary: Molecular Inflammation Board at the Center for Personalized Medicine
Detailed Description: Molecular Inflammation Board at the Center for Personalized Medicine

The study objectives are:

To ensure a prospective documentation of all patients who are referred to the Molecular Inflammation Board in routine clinical care To prospectively ensure the documentation of MEB patients with an emphasis to clinical outcome parameters and further response assessments (e.g. peripheral immunmonitoring, imaging parameters) To prospectively assess patient-reported outcome of MEB patients To evaluate compliance to MEB suggestions in routine clinical care

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: